Sellas Life Sciences Stock Market Value
| SLS Stock | USD 4.26 0.25 5.54% |
| Symbol | Sellas |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sellas Life. If investors know Sellas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sellas Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Sellas Life Sciences is measured differently than its book value, which is the value of Sellas that is recorded on the company's balance sheet. Investors also form their own opinion of Sellas Life's value that differs from its market value or its book value, called intrinsic value, which is Sellas Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sellas Life's market value can be influenced by many factors that don't directly affect Sellas Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sellas Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sellas Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sellas Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sellas Life 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sellas Life's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sellas Life.
| 10/26/2025 |
| 01/24/2026 |
If you would invest 0.00 in Sellas Life on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Sellas Life Sciences or generate 0.0% return on investment in Sellas Life over 90 days. Sellas Life is related to or competes with NeOnc Technologies, Mediwound, Genfit SA, Protara Therapeutics, Invivyd, Codexis, and OmniAb. SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer imm... More
Sellas Life Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sellas Life's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sellas Life Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.92 | |||
| Information Ratio | 0.1835 | |||
| Maximum Drawdown | 34.72 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 14.94 |
Sellas Life Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sellas Life's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sellas Life's standard deviation. In reality, there are many statistical measures that can use Sellas Life historical prices to predict the future Sellas Life's volatility.| Risk Adjusted Performance | 0.1514 | |||
| Jensen Alpha | 1.39 | |||
| Total Risk Alpha | 0.7129 | |||
| Sortino Ratio | 0.2214 | |||
| Treynor Ratio | (12.74) |
Sellas Life January 24, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1514 | |||
| Market Risk Adjusted Performance | (12.73) | |||
| Mean Deviation | 5.46 | |||
| Semi Deviation | 4.9 | |||
| Downside Deviation | 5.92 | |||
| Coefficient Of Variation | 514.13 | |||
| Standard Deviation | 7.15 | |||
| Variance | 51.08 | |||
| Information Ratio | 0.1835 | |||
| Jensen Alpha | 1.39 | |||
| Total Risk Alpha | 0.7129 | |||
| Sortino Ratio | 0.2214 | |||
| Treynor Ratio | (12.74) | |||
| Maximum Drawdown | 34.72 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 14.94 | |||
| Downside Variance | 35.09 | |||
| Semi Variance | 24.01 | |||
| Expected Short fall | (6.44) | |||
| Skewness | 0.3685 | |||
| Kurtosis | 0.2781 |
Sellas Life Sciences Backtested Returns
Sellas Life is risky given 3 months investment horizon. Sellas Life Sciences owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.21, which indicates the firm had a 0.21 % return per unit of risk over the last 3 months. We were able to break down and interpolate twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.56% are justified by taking the suggested risk. Use Sellas Life Sciences Coefficient Of Variation of 514.13, semi deviation of 4.9, and Risk Adjusted Performance of 0.1514 to evaluate company specific risk that cannot be diversified away. Sellas Life holds a performance score of 16 on a scale of zero to a hundred. The entity has a beta of -0.11, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sellas Life are expected to decrease at a much lower rate. During the bear market, Sellas Life is likely to outperform the market. Use Sellas Life Sciences value at risk, as well as the relationship between the kurtosis and price action indicator , to analyze future returns on Sellas Life Sciences.
Auto-correlation | -0.59 |
Good reverse predictability
Sellas Life Sciences has good reverse predictability. Overlapping area represents the amount of predictability between Sellas Life time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sellas Life Sciences price movement. The serial correlation of -0.59 indicates that roughly 59.0% of current Sellas Life price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.59 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.85 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.